Associate Professor,
Department of Pharmacy






Graduated Research Scholars



Thesis Students (FD & HD)
Project: Design and Development of Novel Histone Deacetylase-3 (HDAC3) Inhibitors using Molecular Modeling Studies (Current position: USA)
Position: Researcher, USA
Project: Synthesis of Anticancer Agents
Project: Exploring Mechanisms to Identify Response to Immune Checkpoint Inhibitors (ASTAR, Singapore)
Current position: University of Geneva, Switzerland
Project: Spectroscopic Characterization of Nano-particle Molecule Interactions (Australia)
Current position: PhD student at University of Colorado, USA)
Project: Epigenetic Regulation of NF-kB in Cancer (NTU, Singapore)
Current position: Master Student in the department of neuroscience, Paris
Project: Tumor Stroma Penetrating Nanoparticles for Combination Therapy of Drug Resistant Kidney (Wayne State University, USA). Cancer Current position: University of New York, USA
Project: Operations and Management of Pharmaceutical Products
Project: Value creation in mergers & acquisitions deals involving pharmaceutical industries in India and the subsequent response of the consumers.
Project: Development of Dual pH Sensitive HPMA Conjugated Polymeric System for Effective Delivery of Doxorubicin
Project: Development and Biological Applications of HDAC3 Inhibitors.
Project: Biomimetic Molecular Codes for Therapeutic Gene Modulation
Project: Design, Synthesis and Physicochemical Characterization of HDAC3 inhibitor for Biological Application
Project: Generating higher affinity crystalline gamma s (CRYGS) mutants to reduce inflammation and cataract formation in the eye (Harvard University, USA)
Project: Investigation of the roles of proteolytic machineries of malaria parasites (CCMB, Hyderabad)
Project title: Synthesis and scale up of CMD coated Iron oxide nanoparticles using Confined Impinging Jet mixer for tooth decay and biofilm prevention (Dr David Cormode’s Nanomedicine & Molecular Imaging Lab, University of Pennsylvania, USA
Project Title: Impurity Profiling of Therapeutic Recombinant Monoclonal Antibody. (Serum Institute of India, Pune)
Project title: Screen for sleep-modifying compounds in Drosophila model of Huntington’s disease. (JNCASR)
Project Title: Simultaneous targeting of DPP-4 and HDAC3 by dual inhibitors for the treatment of Type 2 Diabetes
Project title: Development of transdermal formulation of Immunomodulators against melanoma
Project title: Assessment of Indian Health System and Healthcare Financing
Project title: Identification and Design of Selective HDAC3 – PROTACs as Anticancer Therapeutics
Project title: The selective and potent molecules will be further explored in in-vivo study for therapeutic potential amount
23. Peddada Sai Sruthi [FD: ID: 2022A5TS2030H] [Fall 2025]
Project title: Regulatory and Intellectual property at Advagen Pharma that ensures drug marketing, approval and compliance with FDA at Rubican Research, New Jersey, USA
This website uses cookies or similar technologies, to enhance your browsing experience.


